Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients

NCT05933031 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

381

Enrollment

INDUSTRY

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: Tegoprazan 50 mg Triple Therapy
DRUG: Tegoprazan 100 mg Triple Therapy
DRUG: Lansoprazole Triple Therapy

Sponsor

HK inno.N Corporation